AMLODIPINE AND OLMESARTAN MEDOXOMIL Drug Patent Profile
✉ Email this page to a colleague
When do Amlodipine And Olmesartan Medoxomil patents expire, and what generic alternatives are available?
Amlodipine And Olmesartan Medoxomil is a drug marketed by Accord Hlthcare Inc, Ajanta Pharma Ltd, Alembic, Alkem Labs Ltd, Aurobindo Pharma, Glenmark Pharms Ltd, Jubilant Generics, Macleods Pharms Ltd, Micro Labs, Sciegen Pharms Inc, Teva Pharms Usa, Torrent, and Zydus Pharms. and is included in thirteen NDAs.
The generic ingredient in AMLODIPINE AND OLMESARTAN MEDOXOMIL is amlodipine besylate; olmesartan medoxomil. There are fifty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; olmesartan medoxomil profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMLODIPINE AND OLMESARTAN MEDOXOMIL?
- What are the global sales for AMLODIPINE AND OLMESARTAN MEDOXOMIL?
- What is Average Wholesale Price for AMLODIPINE AND OLMESARTAN MEDOXOMIL?
Summary for AMLODIPINE AND OLMESARTAN MEDOXOMIL
US Patents: | 0 |
Applicants: | 13 |
NDAs: | 13 |
Finished Product Suppliers / Packagers: | 15 |
Clinical Trials: | 14 |
What excipients (inactive ingredients) are in AMLODIPINE AND OLMESARTAN MEDOXOMIL? | AMLODIPINE AND OLMESARTAN MEDOXOMIL excipients list |
DailyMed Link: | AMLODIPINE AND OLMESARTAN MEDOXOMIL at DailyMed |
Recent Clinical Trials for AMLODIPINE AND OLMESARTAN MEDOXOMIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Daiichi Sankyo Korea Co., Ltd. | Phase 3 |
Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company | Phase 3 |
Torrent Pharmaceuticals Limited | Phase 1 |